Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 21.75% on an annualized basis producing an average annual return of 34.64%. Currently, Krystal Biotech has a market capitalization of $5.82 billion.
Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $426.51 today based on a price of $203.66 for KRYS at the time of writing.
Krystal Biotech's Performance Over Last 5 Years
![1721656823_0.png](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240722/41069783-0-48cdbfb02ceb573d7767c06112795563.png/big)
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.